Embecta(us:EMBC)

12.63

-0.94%

Updated on 2025-04-02

Open:12.75
Close:12.63
High:13.19
Low:12.57
Prev Close:12.75
Volume:436784.00
Turnover:5.57M
Turnover Ratio:0.75%
Shares:58.13M
MarketCap:734.24M
DateTotalTotal SharesTotal RatioNewIncreasedDecreased
2024-06-303945581714996.78%4591151
2024-03-313845521269795.75%3775167
2023-12-314015535092696.14%4381167
2023-09-304075604993397.76%3379184
2023-06-304445387473194.02%3275209
2023-03-314695540850496.72%5369224
2022-12-3148357802622101.03%5289213
2022-09-305105404732694.73%5668255
dateorgNametotalratiochangeShareschangeRatio
2024-06-30Blackrock Inc.919407215.94%-83319-0.90%
2024-06-30Vanguard Group Inc728835912.64%743671.03%
2024-06-30River Road Asset Management, Llc35836906.21%1368043.97%
2024-06-30Millennium Management Llc34425325.97%2083016.44%
2024-06-30American Century Companies Inc31630735.48%189330.60%
2024-06-30Yacktman Asset Management Lp28153864.88%-1042-0.04%
2024-06-30Deerfield Management Company, L.P. (Series C)27261354.73%0
2024-06-30Fmr Llc24146024.19%101980.42%
2024-06-30State Street Corp23243574.03%-195721-7.77%
2024-06-30Geode Capital Management, Llc13420452.33%339832.60%

About

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.
Address:300 Kimball Drive,Suite 300

Market Movers